Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Patient Information Leaflet last updated on the eMC: 10/06/2011
PIL Yasmin film-coated tablets 0.03mg/3mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 10/06/2011 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • PIL Submitted in error
Updated on 03/06/2011 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change of contra-indications
  • Extra statutory information
  • Improved Electronic Presentation
Updated on 07/12/2010 and displayed until 03/06/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 21/07/2010 and displayed until 07/12/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 19/05/2010 and displayed until 21/07/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 04/07/2008 and displayed until 19/05/2010
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to date of revision
  • Change of licence holder
  • Change to Marketing Authorisation Holder
Updated on 26/11/2007 and displayed until 04/07/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 19/06/2007 and displayed until 26/11/2007
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
Updated on 16/01/2006 and displayed until 19/06/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 21/01/2005 and displayed until 16/01/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 15/07/2002 and displayed until 21/01/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 07/05/2002 and displayed until 15/07/2002
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   ethinylestradiol
   drospirenone